HIT Consultant

SEPTEMBER 21, 2022

a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M Founded in 2017, Naveris is a privately held biotechnology company with facilities in Massachusetts and North Carolina. What You Should Know: – Naveris, Inc. ,

Biotechnology 52

Biotechnology Life Sciences 52

Bill Of Health

DECEMBER 8, 2023

Attorney Gene Quinn offers the most dramatic interpretation, calling the Supreme Court’s embrace of full scope enablement in Amgen “a cataclysmic shift in the law of enablement,” not just for antibodies but for “the life sciences community and beyond.” Amgen’s significance has often been overstated. It was formally repealed in 2018.)

Biotechnology 52

Biotechnology Life Sciences Pharmaceuticals Regulations 52

HIT Consultant

OCTOBER 13, 2022

What You Should Know: – ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The CorriXR Therapeutics team includes experienced biotechnology executives and world-renowned scientists and clinicians. The executive team is led by Eric Kmiec, Ph.D.,

Biotechnology 98

Biotechnology Regulations Prevention Integration 98

HIT Consultant

JUNE 30, 2022

The new research reveals perspectives on the life sciences industry based on an extensive analysis of over 300 M&A deals made by the top 30 biopharma companies between 2010–2021. However, the pace of innovation in life sciences is at an all-time high. Inorganic Growth Strategy.

Life Sciences 52

Life Sciences Biotechnology Integration 52

HIT Consultant

JANUARY 8, 2024

What You Should Know: – Amgen , a global leader in biotechnology, is embarking on a groundbreaking venture: Project Freyja. “Freyja embodies our commitment to leveraging the convergence of technology and biotechnology. Reese, Amgen’s Chief Technology Officer.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

JULY 19, 2023

To help tackle this inequality, gen-t and Omica.bio chose to partner with Lifebit – a leader in secure technology for biomedical research – to ensure the data they are collecting can be accessed, ethically and securely, for life sciences research. In Mexico, Omica.bio is leading a revolution in ethical biotechnology.

Biotechnology 52

Biotechnology Life Sciences Population Health Health Data 52

HIT Consultant

SEPTEMBER 29, 2023

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data-driven precision medicine to obesity treatment, announced it has been awarded the first patent related to its obesity phenotyping technology. – The patent (No.

Biotechnology 105

Biotechnology Life Sciences 105

HIT Consultant

APRIL 6, 2023

a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer and FDA approval to commence a clinical trial of the Biostage Esophageal Implant raises $6M from new and existing investors in a private placement of its shares of common stock. What You Should Know: Biostage, Inc.,

Biotechnology 98

Biotechnology Life Sciences 98

HIT Consultant

OCTOBER 14, 2022

Co-Founder, President, & CEO of Obatala Sciences, Inc. Trivia Frazier, Ph.D., – The funding will be used to further the commercialization of its first-of-kind research-enabling products and platform for drug discovery and development. Funding Accelerates Commercialisation of Research-Enabling Solutions.

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare Innovation Prevention 98

HIT Consultant

OCTOBER 3, 2023

Funding Focused on Disease Treatment, Value Based Care: Funding has shifted away from pandemic-related areas like on-demand healthcare and life science R&D catalysts, which were prominent in 2021 and 2022.

Biotechnology 59

Biotechnology Life Sciences Healthcare 59

GoMoHealth

DECEMBER 9, 2021

This has proven to modify behaviors of patients with chronic and complex conditions worldwide, resulting in significant improvement in health outcomes and adherence, and decreased costs of care for providers, hospitals, health plans, employers, and life science companies.

Biotechnology 93

Biotechnology Life Sciences Integration Hospitals 93

HIT Consultant

AUGUST 23, 2021

Novasenta is one of three local life science startups incubated by UPMC Enterprises in collaboration with Pitt over the last four years and is adding to a growing number of preclinical development programs this partnership is rapidly advancing. Novasenta’s recently hired chief executive officer and a veteran biotechnology leader.

Life Sciences 52

Life Sciences Biotechnology 52

Cloud Blogs

MAY 18, 2021

Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.

Biotechnology 98

Biotechnology Life Sciences Healthcare Innovation Healthcare 98

HIT Consultant

OCTOBER 7, 2021

The firm is continuing to add new pharmaceutical and biotechnology companies to its client base, in new therapeutic areas, and has continued to expand with the addition of over 100 new employees so far in 2021.

Biotechnology 97

Biotechnology Pharmaceuticals Life Sciences 97

Bill Of Health

AUGUST 4, 2022

Not surprisingly, some representatives of the biotechnology industry, and many patent lawyers, reacted negatively to the decision, and have steadily lobbied Congress to restore patent protection for isolated and purified genomic sequences. Myriad Genetics (569 U.S. 576) the U.S.

Biotechnology 123

Biotechnology Life Sciences Pharmaceuticals Healthcare 123

HIT Consultant

OCTOBER 26, 2023

What You Should Know: – Georgiamune , a privately held, clinical stage biotechnology company, and Verily , an Alphabet precision health technology company forms a strategic partnership to advance novel therapeutics for patients with cancer.

Biotechnology 52

Biotechnology Health Technology Integration Life Sciences 52

HIT Consultant

OCTOBER 20, 2023

What You Should Know: Gero , a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to continue internal drug development programs, grow its scientific team to boost platform technology development, and expand its US presence.

Biotechnology 52

Biotechnology Pharmaceuticals Health Data Life Sciences 52

HIT Consultant

DECEMBER 6, 2022

is a life sciences consultant, educator and entrepreneur with extensive experience in pharmaceutical, basic scientific research, clinical medicine, toxicology, chemistry, and drug development. About Frank Fornari, Ph.D. Frank Fornari, Ph.D.,

Doctors 52

Doctors Life Sciences Biotechnology Rehabilitation 52

HIT Consultant

SEPTEMBER 12, 2022

Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. In addition, the Sanderson Study will build the necessary infrastructure to bridge the gap between clinical research and day-to-day clinical impact.

Biotechnology 98

Biotechnology Prevention Health Data Hospitals 98

HIT Consultant

AUGUST 30, 2021

What You Should Know: Fresenius Medical Care (FMC) today announced its plans to invest an additional $25 million in clinical-stage biotechnology platform company Humacyte following the extension of its collaboration in June. Fresenius Medical Care acquired a stake in Humacyte in 2018 for $150M as part of a strategic partnership.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

FEBRUARY 27, 2024

As the CEO of Verix for the past 15 years, it has been his mission to help pharmaceutical and biotechnology companies use data to provide better, more comprehensive care to millions of patients worldwide. He specializes in building and expanding early-stage companies with a customer-centric approach.

Pharmaceuticals 98

Pharmaceuticals Biotechnology Life Sciences 98

HIT Consultant

OCTOBER 12, 2022

Pleno is based in San Diego’s Sorrento Mesa innovation hub proximate to a robust talent pool of experienced scientists, telecommunication engineers, and biotechnology innovators. The company currently employs 24 full-time employees and plans to continue to grow its team rapidly in the coming months.

Biotechnology 52

Biotechnology Life Sciences 52

HIT Consultant

MARCH 13, 2023

What You Should Know: – Pfizer announced it will acquire biotechnology company Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion. The proposed combination enhances Pfizer’s position as a leading company in Oncology.

Biotechnology 52

Biotechnology Life Sciences Healthcare 52

HIT Consultant

SEPTEMBER 20, 2022

What You Should Know: – Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with $72.5M in Series A financing to pioneer novel therapies to modulate mitochondrial function.

Quality Control 52

Quality Control Biotechnology Life Sciences 52

Bill Of Health

JANUARY 24, 2023

By Matthew Chun With its leadership in drug development , biotechnology , and computing technologies , the United States touts itself as being “ the most innovative economy in the world.” innovation in the life sciences and computing fields from 1976-2021. Results The patenting of life sciences innovations in the U.S.

Life Sciences 62

Life Sciences Biotechnology Healthcare 62

HIT Consultant

JANUARY 11, 2022

What You Should Know: – PostEra , a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients.

Biotechnology 52

Biotechnology Integration Life Sciences 52

Bill Of Health

FEBRUARY 18, 2022

The changing landscape of the life sciences industry relies more and more on a form of intellectual property protection called trade secrets to safeguard mechanisms of manufacturing and process knowledge not always included within life science patents. By Matt Bauer.

Life Sciences 82

Life Sciences Pharmaceuticals Biotechnology 82

HIT Consultant

NOVEMBER 3, 2022

Jonathan Montagu is President and Chief Executive Officer at HotSpot Therapeutics , a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune diseases. About Jonathan Montagu.

Biotechnology 98

Biotechnology Pharmaceuticals Healthcare Life Sciences 98

HIT Consultant

OCTOBER 22, 2021

Rebus Biosystems , an Illumina Ventures-backed life science technology company creating?revolutionary?tools?to?advance Calyxt (Nasdaq: CLXT), a plant-based synthetic biotechnology company appoints Seth Dobrin, Ph.D., revolutionary?tools?to?advance to the company’s Scientific Advisory Board. Oculis appoints Dr.

Biotechnology 52

Biotechnology Life Sciences Accountability Accountable Care 52

HIT Consultant

DECEMBER 5, 2022

The National Center for Biotechnology Information (NCBI) reports that decentralized models recruited participants three times faster than the traditional model.

Biotechnology 52

Biotechnology Pharmaceuticals Integration Life Sciences 52

Health Advances

SEPTEMBER 15, 2020

Investors in Hong Kong who are closer to China can better understand the equity story of Chinese biotechnology companies. Following Hong Kong’s steps, Shanghai’s Science and Technology Innovation Market (STAR) changed its criteria to allow pre-revenue biotechs to list in May. explains Chen.

Pharmaceuticals 98

Pharmaceuticals Biotechnology Life Sciences Healthcare 98

Healthcare ECONOMIST

DECEMBER 26, 2023

Biotechnology companies (biotech) or small/medium-sized biopharmaceutical companies (SMEs) are most active in drug discovery, preclinical development and early-stage clinical development. About two-thirds comes from private sector life sciences companies. The paper also lists 7 different archetypes for drug development.

Biotechnology 96

Biotechnology Life Sciences Pharmaceuticals 96

HIT Consultant

JANUARY 28, 2022

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. . – Leah Ray , Chief Customer Officer.

Biotechnology 98

Biotechnology Life Sciences Private Practices Healthcare Analytics 98

HIT Consultant

MAY 30, 2023

Sonia Fischer, Customer Integrations Manager, IQVIA In the age of biotechnology , biosample collection has become an essential part of medical research. Through this process, samples are taken from patients through a variety of sources, including blood, tissue, saliva, hair, and other bodily fluids.

Biotechnology 98

Biotechnology Integration Prevention Patient Experience 98

HIT Consultant

DECEMBER 8, 2022

What You Should Know: – Vevo Therapeutics , an SF-based biotechnology company, launched today with a $12M seed round led by General Catalyst and Wing Venture Capital using its Mosaic in vivo drug discovery platform and next-generation AI models to uncover better drugs for more patients.

Biotechnology 97

Biotechnology Life Sciences 97

HIT Consultant

NOVEMBER 30, 2022

Nectin) a biotechnology company developing novel targeted immunotherapies to address resistance to approved immune-oncology treatments, announced it has extended its Series A financing to over $25 million. What You Should Know: – Nectin Therapeutics Ltd.,

Biotechnology 52

Biotechnology Prevention Life Sciences 52

HIT Consultant

SEPTEMBER 17, 2021

Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Lindsey Irvine as Chief Marketing Officer. OptimizeRx , a provider of digital health solutions for life science companies, physicians and patients appoints Andrew D’Silva as senior vice president of corporate finance.

Biotechnology 98

Biotechnology Life Sciences Hospitals Telemedicine 98